Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection

被引:20
作者
Dai, Wenkui [1 ,2 ,3 ]
Du, Hui [1 ,2 ,3 ]
Li, Shuaicheng [4 ]
Wu, Ruifang [1 ,2 ,3 ]
机构
[1] Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, Shenzhen, Peoples R China
[2] Hong Kong Univ Sci & Technol PKU HKUST, Shenzhen Peking Univ, Med Ctr, Inst Obstet & Gynecol, Shenzhen, Peoples R China
[3] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China
[4] City Univ Hong Kong, Dept Biomed Engn, Hong Kong, Peoples R China
关键词
cervical cancer; high-risk HPV; CVM-targeted intervention; CVM-derived product; HPV clearance; LANGERHANS CELLS; VAGINAL LACTOBACILLI; BACTERIAL VAGINOSIS; TYPE-16; E7; HYDROGEN-PEROXIDE; E-CADHERIN; HPV; PROTEIN; WOMEN; ACTIVATION;
D O I
10.3389/fonc.2021.722639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Persistent high-risk human papillomavirus (hrHPV) infection is the highest risk to cervical cancer which is the fourth most common cancer in women worldwide. A growing body of literatures demonstrate the role of cervicovaginal microbiome (CVM) in hrHPV susceptibility and clearance, suggesting the promise of CVM-targeted interventions in protecting against or eliminating HPV infection. Nevertheless, the CVM-HPV-host interactions are largely unknown. In this review, we summarize imbalanced CVM in HPV-positive women, with or without cervical diseases, and the progress of exploring CVM resources in HPV clearance. In addition, microbe- and host-microbe interactions in HPV infection and elimination are reviewed to understand the role of CVM in remission of HPV infection. Lastly, the feasibility of CVM-modulated and -derived products in promoting HPV clearance is discussed. Information in this article will provide valuable reference for researchers interested in cervical cancer prevention and therapy.
引用
收藏
页数:10
相关论文
共 106 条
[1]   Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 [J].
Adachi, Katsuyuki ;
Kawana, Kei ;
Yokoyama, Terufumi ;
Fujii, Tomoyuki ;
Tomio, Ayako ;
Miura, Shiho ;
Tomio, Kensuke ;
Kojima, Satoko ;
Oda, Katsutoshi ;
Sewaki, Tomomitsu ;
Yasugi, Toshiharu ;
Kozuma, Shiro ;
Taketani, Yuji .
VACCINE, 2010, 28 (16) :2810-2817
[2]   The Interplay Between Reproductive Tract Microbiota and Immunological System in Human Reproduction [J].
Al-Nasiry, Salwan ;
Ambrosino, Elena ;
Schlaepfer, Melissa ;
Morre, Servaas A. ;
Wieten, Lotte ;
Voncken, Jan Willem ;
Spinelli, Marialuigia ;
Mueller, Martin ;
Kramer, Boris W. .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[3]   Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract [J].
Anahtar, Melis N. ;
Byme, Elizabeth H. ;
Doherty, Kathleen E. ;
Bowman, Brittany A. ;
Yamamoto, Hidemi S. ;
Soumillon, Magali ;
Padavattan, Nikita ;
Ismail, Nasreen ;
Moodley, Amber ;
Sabatini, Mary E. ;
Ghebremichael, Musie S. ;
Nusbaum, Chad ;
Huttenhower, Curtis ;
Virgin, Herbert W. ;
Ndung'u, Thumbi ;
Dong, Krista L. ;
Walker, Bruce D. ;
Fichorova, Raina N. ;
Kwon, Douglas S. .
IMMUNITY, 2015, 42 (05) :965-976
[4]   Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women [J].
Anderson, Brenna L. ;
Cu-Uvin, Susan ;
Raker, Christina A. ;
Fitzsimmons, Christine ;
Hillier, Sharon L. .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2011, 90 (05) :510-515
[5]   Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+ [J].
Berggrund, Malin ;
Gustavsson, Inger ;
Aarnio, Riina ;
Lindberg, Julia Hedlund ;
Sanner, Karin ;
Wikstrom, Ingrid ;
Enroth, Stefan ;
Bunikis, Ignas ;
Olovsson, Matts ;
Gyllensten, Ulf .
VIROLOGY JOURNAL, 2020, 17 (01)
[6]   The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis [J].
Borgogna, J. C. ;
Shardell, M. D. ;
Santori, E. K. ;
Nelson, T. M. ;
Rath, J. M. ;
Glover, E. D. ;
Ravel, J. ;
Gravitt, P. E. ;
Yeoman, C. J. ;
Brotman, R. M. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (02) :182-192
[7]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[8]   Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model [J].
Breshears, Laura M. ;
Edwards, Vonetta L. ;
Ravel, Jacques ;
Peterson, Marnie L. .
BMC MICROBIOLOGY, 2015, 15
[9]   SIALIDASES (NEURAMINIDASES) IN BACTERIAL VAGINOSIS AND BACTERIAL VAGINOSIS-ASSOCIATED MICROFLORA [J].
BRISELDEN, AM ;
MONCLA, BJ ;
STEVENS, CE ;
HILLIER, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :663-666
[10]   Interplay Between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus Detection [J].
Brotman, Rebecca M. ;
Shardell, Michelle D. ;
Gajer, Pawel ;
Tracy, J. Kathleen ;
Zenilman, Jonathan M. ;
Ravel, Jacques ;
Gravitt, Patti E. .
JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (11) :1723-1733